Darmstadt, Germany

Hans-Ulrich Petereit

USPTO Granted Patents = 55 


 

Average Co-Inventor Count = 3.5

ph-index = 18

Forward Citations = 966(Granted Patents)

Forward Citations (Not Self Cited) = 904(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1989-2020

Loading Chart...
Loading Chart...
Loading Chart...
55 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Hans-Ulrich Petereit in Pharmaceutical Patents

Introduction: Hans-Ulrich Petereit, based in Darmstadt, Germany, is an esteemed inventor with an impressive portfolio consisting of 55 patents. His work primarily focuses on pharmaceutical innovations, particularly in the development of solid dosage forms and nanoparticles. His contributions to the field have significant implications for drug delivery and release mechanisms.

Latest Patents: Among his most recent patents, Petereit's invention of solid dosage forms with accelerated drug release stands out. This invention comprises a gastric resistant, enteric-coated solid dosage form that includes a core containing a pharmaceutically active ingredient, supported by an inner coating and an outer enteric coating. The inner coating utilizes anionic polymeric material or a water-soluble neutral polymer, combined with a water-soluble inorganic salt that is free of carbonate and bicarbonates. The outer coating consists of a less neutralized anionic polymer that disintegrates quickly in the small intestine at a pH of 5.5 to 7.0. Additionally, his patent on nanoparticles with a maximum diameter in the range of 10-300 nm involves a calcium phosphate nanoparticle core, an active ingredient coating, and successive polymer coatings intended for enhanced delivery.

Career Highlights: Petereit has had a notable career, working with renowned companies such as Evonik Röhm GmbH and Röhm GmbH & Co. Kg. His time at these companies has enabled him to drive some of the significant advancements in pharmaceutical formulations and technologies.

Collaborations: Throughout his career, Petereit has collaborated with talented professionals, including Christian Meier and Erna Roth. These partnerships have fostered an environment of innovation and have played a critical role in the success of his inventions.

Conclusion: Hans-Ulrich Petereit is a prominent figure in the realm of pharmaceutical innovations, with a robust patent portfolio that highlights his expertise and creativity. His contributions not only advance scientific understanding but also enhance practical applications in drug delivery systems, reinforcing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…